Furthermore, D. officinale improved the risk of obesity-associated abnormal lipid metabolism and insulin resistance by enhancing the expression of PPAR-γ, which acts as a potent therapeutic agent for obesity-associated lipid metabolism disorder and insulin resistance (107). The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.